Directory
Antonia Salud Salvia

Antonia Salud Salvia

Degree: PhD


masalud.lleida.ics(ELIMINAR)@gencat.cat

Publications

  • Maria Vieitez, Jose; Garcia-Carbonero, Rocio; Aparicio, Jorge; Feliu, Jaime; Gonzalez-Flores, Encarnacion; Grande, Enrique; Perez-Hoyos, Teresa; Salud, Antonieta; Torres, Esperanza; Valero, Maria; Valladares-Ayerbes, Manuel; Diaz-Rubio, Eduardo

    Recommendations and expert opinion on the adjuvant treatment of colon cancer in Spain.

    CLINICAL & TRANSLATIONAL ONCOLOGY 13 798-804. .

    [doi:10.1007/s12094-011-0736-4]

  • Nogue, Miguel; Salud, Antonieta; Vicente, Pilar; Arrivi, Antonio; Maria Roca, Jose; Losa, Ferran; Ponce, Jose; Jose Safont, Maria; Guasch, Inmaculada; Moreno, Isabel; Ruiz, Ana; Pericay, Carles

    Addition of bevacizumab to XELOX induction therapy plus concomitant capecitabine-based chemoradiotherapy in magnetic resonance imaging-defined poor-prognosis locally advanced rectal cancer: the AVACROSS study.

    Oncologist 16 614-620. .

    [doi:10.1634/theoncologist.2010-0285]

  • Bielsa, Silvia; Hernandez, Paula; Rodriguez-Panadero, Francisco; Taberner, Teresa; Salud, Antonieta; Porcel, Jose M.

    Tumor type influences the effectiveness of pleurodesis in malignant effusions.

    Lung 189 151-155. .

    [doi:10.1007/s00408-011-9283-6]

  • Feliu, J.; Safont, M. J.; Salud, A.; Losa, F.; Garcia-Giron, C.; Bosch, C.; Escudero, P.; Lopez, R.; Madronal, C.; Bolanos, M.; Gil, M.; Llombart, A.; Castro-Carpeno, J.; Gonzalez-Baron, M.

    Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer.

    BRITISH JOURNAL OF CANCER 102 1468-1473. .

    [doi:10.1038/sj.bjc.6605663]

  • Fernandez-Martos, Carlos; Pericay, Carles; Aparicio, Jorge; Salud, Antonieta; Safont, MariaJose; Massuti, Bertomeu; Vera, Ruth; Escudero, Pilar; Maurel, Joan; Marcuello, Eugenio; Luis Mengual, Jose; Saigi, Eugenio; Estevan, Rafael; Mira, Moises; Polo, Sonia; Hernandez, Ana; Gallen, Manuel; Arias, Fernando; Serra, Javier; Alonso, Vicente

    Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study.

    Journal of Clinical Oncology 28 859-865. .

    [doi:10.1200/JCO.2009.25.8541]

  • Roca, Jose-Maria; Alonso, Vicente; Pericay, Carles; Escudero, Pilar; Salud, Antonieta; Losa, Ferran; Lopez, Luis-Jesus; Guasch, Imma; Mendez, Miguel; Quintero-Aldana, Guillermo; Grande, Carlos; Vicente, Pilar; Arrivi, Antonio; Martin, Cristina; Moreno, Isabel; Garcia, Pilar; Anton, Isabel; Constenla, Manuel; Yubero, Alfonso; Cirera, Luis; ACROSS Cooperative Grp

    Cetuximab Given Every 2 Weeks plus Irinotecan Is an active and Safe Option for Previously Treated Patients with Metastatic Colorectal Cancer

    Chemotherapy 56 142-146. .

    [doi:10.1159/000313527]

  • Bielsa, Silvia; Esquerda, Aureli; Salud, Antonieta; Montes, Ana; Arellano, Elena; Rodriguez-Panadero, Francisco; Porcel, Jose M.

    High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions.

    EUROPEAN JOURNAL OF INTERNAL MEDICINE 20 383-386. .

    [doi:10.1016/j.ejim.2008.11.009]

  • Bielsa, Silvia; Salud, Antonieta; Martinez, Montserrat; Esquerda, Aureli; Martin, Antonio; Rodriguez-Panadero, Francisco; Porcel, Jose M.

    Prognostic significance of pleural fluid data in patients with malignant effusion.

    EUROPEAN JOURNAL OF INTERNAL MEDICINE 19 334-339. .

    [doi:10.1016/j.ejim.2007.09.014]

  • Bielsa, S.; Panades, M. J.; Egido, R.; Rue, M.; Salud, A.; Matias-Guiu, X.; Rodriguez-Panadero, F.; Porcel, J. M.

    ACCURaCY OF PLEURaL FLUID CYTOLOGY IN MaLIGNaNT EFFUSIONS

    Anales De Medicina Interna 25 173-177. .

  • Bielsa S; Panadés MJ; Egido R; Rue M; Salud A; Matías-Guiu X; Rodríguez-Panadero F; Porcel JM

    Rentabilidad del estudio citológico del líquido pleural en el derrame maligno.

    Anales De Medicina Interna 25 173-177. .

  • Porcel, JM; Salud, A; Nabal, M; Vives, M; Esquerda, A; Rodriguez-Panadero, F

    Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions.

    SUPPORTIVE CARE IN CANCER 14 475-478. .

    [doi:10.1007/s00520-005-0001-x]

  • Feliu, J; Salud, A; Escudero, P; Lopez-Gomez, L; Bolanos, M; Galan, A; Vicent, JM; Yubero, A; Losa, F; De Castro, J; de Mon, MA; Casado, E; Gonzalez-Baron, M; Oncopaz Cooperative Grp

    XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

    BRITISH JOURNAL OF CANCER 94 969-975. .

    [doi:10.1038/sj.bjc.6603047]

Projects

  • Ajuts per a la contractació de personal investigador novell (FI)
  • Predicción de micrometástasis en pacientes con cáncer de colon localizado de alto riesgo
  • Dimerizaciones de HER2 como elemento de decición en la terapia dirigida anti-HER2 frente al cáncer de mama
  • UTILITAT PRONOSTICA DELS PERFILS D'EXPRESSIO PROTEICA EN PACIENTS AMB TUMOR RESIDUAL VIABLE (>1.0 CM) DESPRES DE LA QUIMIOTERAPIA NEOADJUVANT EN CANCER DE MAMA
  • Cáncer de mama: utilidad pronóstica de los Perfiles de Expresión Proteica en pacientes con tumor residual viable (>1.0 cm) tras quimioterapia neoadyuvante